TAK

#465
Takeda Pharmaceutical Company Limited American Depositary Share
15.9 7 USD
+9782.43%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
15.95
15.98
Faixa anual
0.16
18.89
Mudança diária
+9782.43%
Mudança mensal
-4.37%
Mudança em 6 meses
+10.06%
Mudança anual
+12.58%
Fechamento anterior
0.1 6
Open
15.9 7
Mínimo
15.9 5
High
15.9 8
Volume
809
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor 20202021202220232024 TTM

Takeda Pharmaceutical Company Limited American Depositary Share

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

Notícias